From January 1, 2022 to March 31, 2022, the company has repurchased 4,478,900 shares, representing 0.82% for CNY 69.74 million. With this, the company has completed the repurchase of 11,355,900 shares, representing 2.09% for CNY 174.83 million under the buyback announced on August 4, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.8 CNY | +3.77% |
|
-1.46% | -5.98% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.98% | 652M | |
+58.19% | 823B | |
-6.55% | 353B | |
+16.01% | 320B | |
+7.47% | 295B | |
+13.79% | 239B | |
+14.68% | 220B | |
-0.49% | 219B | |
+8.95% | 167B | |
-2.83% | 159B |
- Stock Market
- Equities
- 300497 Stock
- News Jiangxi Fushine Pharmaceutical Co., Ltd.
- Tranche Update on Jiangxi Fushine Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 4, 2021.